COST-EFFECTIVENESS OF CARDIAC RESYNCHRONISATION THERAPY FOR PATIENTS WITH MODERATE-TO-SEVERE HEART FAILURE

被引：0
|
作者：
Neyt, M. [1 ]
Stroobandt, S. [1 ]
Obyn, C. [1 ]
Camberlin, C. [1 ]
Devriese, S. [1 ]
De Laet, C. [1 ]
Van Brabandt, H. [1 ]
机构：
[1] Belgian Hlth Care Knowledge Ctr, Brussels, Belgium
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.121
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A253 / A253
页数：1
相关论文
共 50 条
  • [11] Cost-Effectiveness of Cardiac Resynchronization Therapy in Patients with Heart Failure in Thailand
    Permsuwan, Unchalee
    Phrommintikul, Arintaya
    Silavanich, Voratima
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2020, 12 : 579 - 588
  • [12] Cost-effectiveness of cardiac resynchronization therapy in patients with symptomatic heart failure
    Nichol, G
    Kaul, P
    Huszti, E
    Bridges, JFP
    ANNALS OF INTERNAL MEDICINE, 2004, 141 (05) : 343 - 351
  • [13] Cost-effectiveness of cardiac resynchronisation therapy in clinical practice
    Leyva, F.
    Chalil, S.
    Caro, J.
    Guo, S.
    Mailk, F.
    Oliver, E.
    Muhyaldeen, S. A.
    Smith, R. E. A.
    EUROPEAN HEART JOURNAL, 2006, 27 : 612 - 612
  • [14] Cost-effectiveness of cardiac resynchronization therapy in heart failure
    Santini, M
    Ricci, R
    EUROPEAN HEART JOURNAL, 2003, 24 (09) : 879 - 879
  • [15] Cost-Effectiveness of Tofacitinib for Patients with Moderate-to-Severe Rheumatoid Arthritis in China
    Tian, Lei
    Xiong, Xiaomo
    Guo, Qiang
    Chen, Yixi
    Wang, Luying
    Dong, Peng
    Ma, Aixia
    PHARMACOECONOMICS, 2020, 38 (12) : 1345 - 1358
  • [16] Cost-Effectiveness of Tofacitinib for Patients with Moderate-to-Severe Rheumatoid Arthritis in China
    Lei Tian
    Xiaomo Xiong
    Qiang Guo
    Yixi Chen
    Luying Wang
    Peng Dong
    Aixia Ma
    PharmacoEconomics, 2020, 38 : 1345 - 1358
  • [17] COST-EFFECTIVENESS OF APREMILAST IN MODERATE-TO-SEVERE PSORIASIS IN CANADA
    Cawston, H.
    Damera, V
    Ektare, V
    Shear, N. H.
    Tencer, T.
    Liu, F. F.
    VALUE IN HEALTH, 2016, 19 (07) : A587 - A587
  • [18] Cost-effectiveness of abatacept for moderate-to-severe rheumatoid arthritis
    Tsao, Nicole W.
    Shojania, Kam
    Marra, Carlo A.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2014, 14 (01) : 9 - 18
  • [19] Cost-effectiveness of spironolactone in patients with severe heart failure
    L Tilson
    B McGowan
    M Ryan
    M Barry
    Irish Journal of Medical Science, 2003, 172 : 70 - 72
  • [20] Cost-effectiveness of spironolactone in patients with severe heart failure
    Tilson, L
    McGowan, B
    Ryan, M
    Barry, M
    IRISH JOURNAL OF MEDICAL SCIENCE, 2003, 172 (02) : 70 - 72
12345